Health Care and Manufacturing

Perrigo transfers stock listing to NYSE

May 28, 2013
| By Pete Daly |
TAGS Perrigo
Print
Text Size:
A A
Perrigo acquires Rosemont Pharmaceuticals for $283M to expand in U.K.
Allegan-based Perrigo is a global manufacturer of store brand over-the-counter and generic prescription pharmaceuticals. Photo via fb.com

Perrigo has announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange from the NASDAQ Global Select Market.

Allegan-based Perrigo (Nasdaq: PRGO) expects to begin trading on the NYSE on June 6 under its current stock symbol, PRGO, and will continue to trade on NASDAQ until the transfer takes place.

Perrigo Chairman and CEO Joseph C. Papa stated, “We are looking forward to listing on the NYSE, as this change will provide increased visibility and enhanced services that will benefit our shareholders."

“Perrigo and the NYSE are a perfect fit, and we're thrilled to welcome one of the world's leading health care suppliers to the world’s leading equities market,” said Duncan Niederauer, chief executive officer, NYSE Euronext. “Perrigo was founded more than a century ago, seeking to best serve and empower customers, continually innovate and deliver quality products. That vision, which remains in place today, set the stage for the company's growth and global leadership.

"On behalf of my NYSE Euronext colleagues, I want to thank Joe Papa and the Perrigo board for choosing the NYSE," Niederauer said. "We look forward to building an outstanding partnership with the entire Perrigo team and the company’s shareholders.”

To celebrate the transfer, representatives of Perrigo will ring the NYSE opening bell on June 6 at 9:30 a.m., which will be broadcast live on the company's website at perrigo.com.

From its beginnings as a packager of generic home remedies in 1887, Perrigo has grown to become a leading global provider of health care products.

The company is the world's largest manufacturer of over-the-counter pharmaceutical products for the store-brand market. 

Perrigo develops, manufactures and distributes OTC and generic prescription pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients.

The company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia.

Recent Articles by Pete Daly

Editor's Picks

Comments powered by Disqus